Izinga lokusinda lichazwa njengepesenti yabantu abasinda kwisifo esifana nesifo somhlaza kwisithuba esithile esithile. Ngokomzekelo, ukuba umlinganiselo weminyaka emihlanu wokusinda komhlaza othile ungama-34 ekhulwini, oku kuthetha ukuba abantu abangama-34 kwabangama-100 ekuqaleni bafumana ukuba lowo mhlaza uza kuphila emva kweminyaka emi-5. Izinga lokusinda alibonakali ukuba umhlaza uphiliswa okanye ukuba unyango lugqityiwe.
Ukusinda eM median
Elinye ixesha eliqhelekileyo lisetyenziselwa xa uthetha malunga namazinga okusinda kukuphila kwangaphakathi . Isikhathi sokusinda eM median isixa seminyaka emva kokuba i-50 pesenti yabantu sele ifile, kwaye i-50 ekhulwini isaphila. Uninzi lweengxelo zekliniki zibika ukuphila kwangaphakathi kunokuba kufikeleleke izinga lokusinda, ngokukodwa kwii-cancer eziphambili.
Ukusinda ngokubanzi (OS)
Ukuphila ngokubanzi (OS) elinye igama eliqhelekileyo lisetyenziswe ngokubhekiselele kwonyango lomhlaza. Libhekisela kwixesha eliqala ukuxilongwa (okanye ekuqaleni kwonyango) kwaye kufike ngexesha lokufa. Ngokuqhelekileyo kusetyenziswa njengendlela yokubonisa ukuba unyango lusebenza njani.
Ukusinda Okungenakuqhubekayo (PFS)
Ukuqhubekeka kokusasazeka (PFS) igama eliqhelekileyo lisetyenziswe kwizilingo zonyango ukuvavanya amachiza amatsha kunye nonyango. Libhekisela kwisixa sithuba phakathi koxa unyango lomhlaza luqala, kwaye xa umhlaza uphumela okanye ukufa kuvela.
Ukusinda Okungenazifo
Ukusinda kwama -free-free is a standard number of people who are expected to be free from cancer for a particular amount of time.
Kanti ngamanye amaxesha kuthiwa "ukusinda okungazange kwenzeke kwakhona." Qaphela ukuba ukusinda ngokubanzi kubandakanya bobabini abasindayo ngaphandle kobungqina bomhlaza kunye nalabo abasinda kodwa banomdlavuza okwenkwenkwe yabo.
Ubomi obuKodwa
Ubomi obuthile bokuba yinto ebalulekileyo kwizifundo zekliniki kwaye ibhekisela kwinani labantu abahlala emdlalweni othile emva kwesithuba sexesha.
Umzekelo uyindlela elula yokuchaza oku. Nangona ukusinda jikelele kumdlavuza wamaphaphu akubandakanyi nje kuphela abo bantu abafa ngumdlavuza wamaphaphu, kodwa kunye nesifo senhliziyo, ezinye i-cancer, kunye nenye nayiphi imeko, kubangelwa ukusukela ngokukhethekileyo kubhekisela kuphela kumathuba omntu oza kusinda ngumdlavuza wamaphaphu wedwa. Oku kubalulekile ekuphononongeni unyango olunokwenzeka. Isilonda esinamandla esiyingozi esonakalisa intliziyo sinokunyusa ukususelwa kwimiba ethile yomdlavuza wamaphaphu kodwa okuncinci kunganciphisa izinga lokusasazeka ngokubanzi ngenxa yokufa kwintliziyo yesifo.
Ukusinda Kwemicimbi
Ukusinda kwenzeka-ntengiso kubhekisela kwipesenti yabantu abaphila ngaphandle kwengxaki ethile ngexesha elide. Ngokomzekelo, eli gama lingabonisa inani labantu abangazange bahlakulele iimpawu zeengqondo okanye iintlungu zethambo ngenxa yokusasazeka komdlavuza wamaphaphu kwintliziyo okanye amathambo.
I-Cancer Survival Rates nge Type and Stag
Eli nqaku lichaza uluhlu olusinda kwiinkalo ezahlukeneyo kunye namanqanaba omhlaza wemiphunga. Qaphela ukuba nangona hlobo olufanayo kunye nesigaba, iisomhlaza ziyahluke kwaye zonke zifumane iiprofayili ezahlukeneyo. Ezi ziphinde zaphulwa zingena:
- Isigaba 3A Isalathisi esincinci
- Isigaba se-3B esingekho encinane yeSeli
- Isigaba sesi-4 (iMetastatic) Iseli elincinci
- I-Small Cell Lung Cancer - I-Stage Limited
- Incinci yeSifo seLung Cancer - I- Stage Stage
Izibalo zoLwazi lokuSinda
Hlalani nikhumbule ukuba izinga lokusinda lisekelwe kwiinkcukacha kwaye zijonge abantu ngokubanzi. Ukugqithisa kwakho okungafaniyo kuxhomekeke kwiimpawu ezininzi ezifana nempilo yakho jikelele, kunye nonyango olutsha oluye lwafumaneka. Ngethuba ixesha lokusasazwa kwimivuzo lipapashwa, amanani amaninzi aneminyaka emininzi ubudala. Ngokomzekelo, xa kuxela umlinganiselo weminyaka emihlanu yokusinda ngohlobo kunye nesigaba somdlavuza, iinani likhangele abantu abaye bafumanisa ubuncinane ubuncinane iminyaka emi-5 ngaphambi kokuba iziphumo zokufunda zichazwe.
Ngokuqhubela phambili kwonyango lwee-cancer eziphambili, la manani angathathi iinguqulelo zeengxelo kwiingcebiso zonyango zangoku, kwaye izinga lakho lokuphila elindelekileyo lingaba likhulu kakhulu.
Ngokuphathelele umhlaza wamaphaphu, kubaluleke ngakumbi ukuba ucinge ukuba amazinga okusinda angeke abonakalise isiphumo sakho kwisifo. Kukho ezininzi iinkqubela phambili zonyango, kwaye umzekelo unokunceda ukucacisa oku bhetele. Phakathi kuka-2011 kunye no-2015 kukho ezinye iindlela ezintsha zonyango ezivunyiwe kumhlaza womphunga-nokuba ngumhlaza wamaphaphu ophakamileyo-owawuvunyiwe kwiminyaka engama-40 ngaphambi ko-2011. Ngo-2016, kukho izixhobo ezininzi ezivanywayo kwiimvavanyo zeclini yomdlavuza wamaphaphu nawuphi na uhlobo lomhlaza. Ukuba usandul 'ukuba ufumane umdlavuza wamaphaphu, khumbula ukuba kukho izizathu ezininzi zokuziva unethemba.
Imithombo:
American Cancer Society. Amanqanaba angapheliyo kwiNtsholongwane yeCarcer Lung Cancer. Ukuhlaziywa 05/16/16. http://www.cancer.org/cancer/lungcancer-non-smallcell/detailedguide/non-sall-cell-lung-cancer-survival-rates